Global COVID-19 Vaccine Spending Estimated At $157bn Through 2025 By IQVIA
Vaccine spending projections represent about 2% of total spending on medicines IQVIA said. Increased spending will be partly offset by COIVD-19 disruptions, however.
You may also be interested in...
Janssen's net drug prices declined for the fourth year in a row in 2020, while list prices increased 3.8%, according to the company's drug pricing report.
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
The first targeted C3 therapy was approved by the US FDA for treatment-naïve patients as well as those switching from Alexion's Soliris or Ultomiris.